Therefore, syngeneic Balb/c mice with intact immune systems were subsequently utilized to determine whether BHS can chemosensitise breast cancer in immunocompetent mice by inhibiting the EV‐Apo/TAM/PD‐L1 pathway. The gene discussed is CD274; the disease is breast cancer.